Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02784483
Title Pilot Study Of Anti-Programmed Death Ligand-1 (Anti-PD-L1, Atezolizumab) In Asymptomatic Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University
Indications

multiple myeloma

Therapies

Atezolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.